Romvimza™ (vimseltinib) – New drug approval
February 14, 2025 - Ono Pharmaceutical’s announced the FDA approval of Romvimza (vimseltinib), for treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity.
Top